CLINICAL_TRIALS trial_result · 2018-11-02

Clinical Trial Update: Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects [Phase 3]

A Phase 3 trial of CCR5 antagonist GW873140 in treatment-experienced HIV patients was terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I | Phase 3 | Status: TERMINATED | Results posted: 2018-11-02